Tinker, Anna V.
BC Cancer Agency
4 papers on CoChatORCID 0000-0002-1190-7746
Most cited papers
- Verified
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
Swisher, E. M., Lin, K. K., Oza, A. M., Scott, C. L., Giordano, H., Sun, J., Konecny, G. E., Coleman, R. L., Tinker, A. V., O'Malley, D. M., et al. (2017) · The Lancet Oncology
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 1,196
- Verified
“Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?
Davis, A., Tinker, A. V., & Friedlander, M. (2014) · Gynecologic Oncology
Ovarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments
Cited by 433
- Verified
Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies
Hilton, J., Gelmon, K., Bedard, P. L., Tu, D., Xu, H., Tinker, A. V., Goodwin, R., Laurie, S. A., Jonker, D., Hansen, A. R., et al. (2022) · Nature Communications
DNA and Nucleic Acid ChemistryPARP inhibition in cancer therapy
Cited by 155
- Verified
Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation
Hoskins, P. J., Le, N., Gilks, B., Tinker, A., Santos, J., Wong, F., & Swenerton, K. D. (2012) · Journal of Clinical Oncology
Ovarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments
Cited by 117
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free